Clinical Trial Update: Study of Treatment for HPV16+ ASC-US or LSIL [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a treatment for HPV16-positive cervical cytology abnormalities (ASC-US or LSIL), currently recruiting at the University of Ala…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia
• Human Papillomavirus Infection

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: ASC-US, LSIL | Phase 1 | Status: RECRUITING